Treatment of Cognitive Impairment in Multiple Sclerosis: Is the Use of Acetylcholinesterase Inhibitors a Viable Option?

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.2, 2008-01, pp. : 87-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccines Against Drugs of Abuse: A Viable Treatment Option?

By Kantak K.M.

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 341-352

Adis International

Access to resources Recommend Favorite

Calcineurin Inhibitors in Renal Transplantation: What is the Best Option?

By Tanabe K.

Drugs, Vol. 63, Iss. 15, 2003-01 ,pp. : 1535-1548

Adis International

Access to resources Recommend Favorite

Do Acetylcholinesterase Inhibitors Have a Role in Improving Cognitive Impairment in Patients with Schizophrenia?

By Alessandro Lenzi Daniela Tuscano

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. : 139-148

Adis International

Access to resources Recommend Favorite

Diamorphine-assisted substitution treatment: an effective option?

Inpharma, Vol. 1, Iss. 1312, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Diamorphine-assisted substitution treatment: an effective option?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 337, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite